featured
Dr. Warren Heymann on Topical Nitroglycerin: Uses That May Detonate Existing Therapeutic Paradigms
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Ismail D, Coulson I. Raynaud disease phenomenon. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I (eds). Treatment of Skin Disease, Fifth Edition. Elsevier, London, 2018, Ch 215.
- Curtiss P, Schwager Z, Cobos G, et al. A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud’s phenomenon. J Am Acad Dermatol. 2018;78(6):1110-1118.
- Flynn V, Chisholm C, Grimwood R. Topical nitroglycerin: A promising treatment option for chondrodermatitis nodularis helicis. J Am Acad Dermatol. 2011;65(3):531-536.
- Kechichian E, Jabbour S, Haber R, et al. Management of chondrodermatitis nodularis helicis: A systematic review and treatment algorithm. Dermatol Surg. 2016;42(10):1125-1134.
- Verma P, Singal A, Yadav P. Perniosis in an infant treated with topical nitroglycerine. Pediatr Dermatol. 2013;30(5):623-624.
-
Verma P. Topical nitroglycerine in perniosis/chilblains. Skinmed. 2015;13(3):176-177.
- Kleydman K, Cohen JL, Marmur E. Nitroglycerin: a review of its use in treatment of vascular occlusion after soft tissue augmentation. Dermatol Surg. 2012;38(12):1889-1897.